Humulin R
Showing 1 - 25 of 2,819
Diabetes, Type 2 Trial in Graz (AT278, NovoRapid, Humulin R 500 UNT/ML Injectable Solution)
Recruiting
- Diabetes Mellitus, Type 2
- AT278
- +2 more
-
Graz, AustriaClinical Trials Unit, Medical University of Graz
Mar 3, 2023
Healthy Volunteers Trial in Neuss (Biocon's Human Insulin R U-500, Humulin® R U-500 (US Reference Product))
Recruiting
- Healthy Volunteers
- Biocon's Human Insulin R U-500
- Humulin® R U-500 (US Reference Product)
-
Neuss, GermanyProfil Institut für Stoffwechselforschung GmbH 9
Jun 9, 2022
Bioequivalence, Therapeutic Equivalency Trial in Moscow (Humulin® Regular, Rinsulin® R)
Completed
- Bioequivalence
- Therapeutic Equivalency
- Humulin® Regular
- Rinsulin® R
-
Moscow, Russian Federation"National Medical Research Center of Endocrinology" of the Minis
Sep 15, 2023
Healthy Trial in Ann Arbor (Intranasal insulin)
Recruiting
- Healthy
- Intranasal insulin
-
Ann Arbor, MichiganUniversity of Michigan
Nov 16, 2023
Out-Of-Hospital Cardiac Arrest, Healthy Trial in Ann Arbor (Intranasal insulin)
Completed
- Out-Of-Hospital Cardiac Arrest
- Healthy
- Intranasal insulin
-
Ann Arbor, MichiganUniversity of Michigan
Oct 13, 2022
Type 1 Diabetes Trial in Bobo-Dioulasso, Ouagadougou (premix insulin human isophane suspension and insulin human, Humulin N plus
Not yet recruiting
- Type 1 Diabetes
- premix insulin human isophane suspension and insulin human
- Humulin N plus Humulin R
-
Bobo-Dioulasso, Houet, Burkina Faso
- +2 more
Mar 12, 2023
Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (drug, other, device)
Active, not recruiting
- Mild Cognitive Impairment
- Cognitive Impairment
- Insulin
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jan 27, 2023
Healthy Volunteer Trial in Mainz (Biocon Insulin R, Humulin®R)
Completed
- Healthy Volunteer
- Biocon Insulin R
- Humulin®R
-
Mainz, GermanyProfil Mainz GmbH
Jul 27, 2021
Mild Cognitive Impairment, Cognitive Impairment Trial in Winston-Salem (20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly &
Active, not recruiting
- Mild Cognitive Impairment
- Cognitive Impairment
- 20 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
- 40 IU Humulin® R U-100 (NDC: 0002-8215, Eli Lilly & Company)
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 2, 2021
Glucose, High Blood Trial in Palm Beach Gardens (Human Insulin, Finger-actuated, Metered Pump Sprayer)
Not yet recruiting
- Glucose, High Blood
- Human Insulin
- Finger-actuated, Metered Pump Sprayer
-
Palm Beach Gardens, FloridaLangford Research Institute
Aug 3, 2022
Burns Trial in Toronto (Humulin R, Metformin)
Completed
- Burns
- Humulin R
- Metformin
-
Toronto, Ontario, CanadaRoss Tilley Burn Centre, Sunnybrook Health Sciences Centre
Mar 24, 2022
Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,
Not yet recruiting
- Insulin Resistance
- +3 more
- Insulin human
- +11 more
-
New York, New YorkColumbia University Irving Medical Center
Nov 6, 2023
Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)
Recruiting
- Type 1 Diabetes
- Diabetes Mellitus, Type 1
- Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
- Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
-
Westmead, New South Wales, Australia
- +5 more
Feb 15, 2023
Hypertension Trial in Dallas (DEFINITY® infusion, Human Recombinant Regular Insulin infusion, Dextrose infusion)
Recruiting
- Hypertension
- DEFINITY® infusion
- +6 more
-
Dallas, TexasUT Southwestern Medical Center
Mar 22, 2022
Diabetes, Type 2, Diabetes, Type 1 Trial in New York, Mainz (3 hours humulin R 100 IU/mL PIT, 2 hours humulin R 100 IU/mL PIT)
Completed
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
- 3 hours humulin R 100 IU/mL PIT
- 2 hours humulin R 100 IU/mL PIT
-
New York, New York
- +1 more
Mar 30, 2021
Mild Cognitive Impairment, Cognitive Impairment, Alzheimer, Early Onset Trial (Insulin (Humulin® R U-100), Placebo, Aptar Pharma
Not yet recruiting
- Mild Cognitive Impairment
- +2 more
- Insulin (Humulin® R U-100)
- +2 more
- (no location specified)
May 31, 2022
MDD, Bipolar Disorder, Anhedonia Trial in Toronto (Humulin R, Diluent)
Recruiting
- Major Depressive Disorder
- +3 more
- Humulin R
- Diluent
-
Toronto, Ontario, CanadaToronto Western Hospital
Oct 6, 2021
Delirium, Heart Diseases Trial in Montreal (Regular Insulin, Human 100 UNT/ML, Normal Saline Flush, 0.9% Injectable Solution)
Not yet recruiting
- Delirium
- Heart Diseases
- Regular Insulin, Human 100 UNT/ML
- Normal Saline Flush, 0.9% Injectable Solution
-
Montreal, Quebec, CanadaRoyal Victoria Hospital McGill University Health Centre
Oct 13, 2021
Type1diabetes Trial in Minneapolis (Regular insulin (Humulin-R), intranasal route, SipNose intranasal device)
Terminated
- Type1diabetes
- Regular insulin (Humulin-R), intranasal route
- SipNose intranasal device
-
Minneapolis, MinnesotaHealth Partners Institute dba International Diabetes Center
Apr 26, 2021
Mild Cognitive Impairment, Cognitive Impairment, Alzheimer Trial in Winston-Salem (Insulin (Humulin® R U-100), Empagliflozin 10
Recruiting
- Mild Cognitive Impairment
- +2 more
- Insulin (Humulin® R U-100)
- +4 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences / Wake Forest School of M
Nov 10, 2021
Cognitive Decline, Heart Diseases, Delirium Trial (Regular insulin, Normal Saline Flush, 0.9% Injectable Solution)
Not yet recruiting
- Cognitive Decline
- +2 more
- Regular insulin
- Normal Saline Flush, 0.9% Injectable Solution
- (no location specified)
Jan 25, 2021
Ischemic Heart Disease, Aortic Aneurysm Trial in Montreal (Humulin R, Normal Saline)
Recruiting
- Ischemic Heart Disease
- Aortic Aneurysm
- Humulin R
- Normal Saline
-
Montreal, Quebec, CanadaRoyal Victoria Hospital McGill University Health Centre
Feb 23, 2021
HIV Associated Neurocognitive Disorder (HAND) Trial in Calgary (IN insulin, Sterile Saline )
Terminated
- HIV Associated Neurocognitive Disorder (HAND)
- IN insulin
- Sterile Saline placebo
-
Calgary, Alberta, CanadaSouthern Alberta Clinic
Jun 9, 2020
Type 1 Diabetes Trial in Worldwide (67.5 mg oral insulin crystals daily, 500mg oral insulin crystals every other week)
Completed
- Type 1 Diabetes
- 67.5 mg oral insulin crystals daily
- 500mg oral insulin crystals every other week
-
San Francisco, California
- +18 more
Jul 24, 2020